chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Post vaccines pt wouldn't walk for 3 weeks with fever. Cried, wouldn't eat. Lost weight.
The day after I received vaccine I had severe arm pain at injection site, my body was achy , and fatigue. These symptoms resolved after a few days . I then had dizziness, nausea, unbalanced when walking, chest pain, feeling like my heart was racing,  palpatations, muscle weakness in my legs, and brain fog. The unbalanced feeling, dizziness, weakness ,and occasional palpatations remain. I had a covid test done on 1/6/2021.I had sinus pain started on 1/8/2021. I am being treated for possible sinus infection with Augmentin that I started on 1/11/2021 but my symptoms are still present . I have been unable to work because when I walk I feel dizzy and unsteady.  I have follow up with my primary doctor on 1/18/2021.
This spontaneous report as received from a medical assistant refers to a 25 year old female patient. Information on pertinent medical history and concurrent condition was not provided. On 21-OCT-2016, the patient was vaccinated with first dose of GARDASIL 9 lot # M014929, expiry date: 27-MAY-2017 (dose and route not reported) for prophylaxis. On 31-JUL-2017, she was vaccinated second dose of GARDASIL 9 (inappropriate schedule of drug administration). No adverse effects. No product quality complaint (PQC) involved. Additional information is not expected.
Sore arm; This case was reported by a physician via sales rep and described the occurrence of pain in arm in an unspecified number of patients who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, unknown after receiving Bexsero, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Bexsero.  Additional details were reported as follows: The age at vaccination was not reported. The Physician made a general statement regarding Bexsero adverse event of sore arm based on his clinical experience with Bexsero. The reporter did not give consent for follow up.
Parents brought child to ER with concern of facial swelling/allergic reaction. ER notes state: 'Well child check. I am not seeing any obvious sign of allergic reaction or respiratory distress and child appears to be well hydrated.' Review of systems noted on record were all normal except for temp of 99.3.
Patient who recieved 1st  dose of vaccine in 2018 never get the 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose of Shingrix in 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 19-May-2022 Reporter's comment: Called with the following inquiry in regards of Shingrix. The reporter had a patient who received one dose of vaccine in 2018, did they need to repeat the entire series. When asked for clarification details for patient and vaccination, the reporter stated she had no data available on this. The VARES details were for 1st dose. Consented to follow-up. Additional Supportive Information: Till the time of reporting, the patient did not receive the second dose of Shingrix, which led to incomplete course of vaccination. Note: Vaers details were added to second dose but it was related to first dose.
Elevated blood glucose; This case was reported by a pharmacist via call center representative and described the occurrence of blood glucose increased in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 8th October 2019, the patient received Shingrix. In October 2019, less than a week after receiving Shingrix, the patient experienced blood glucose increased. On an unknown date, the outcome of the blood glucose increased was unknown.   It was unknown if the reporter considered the blood glucose increased to be related to Shingrix.  Additional information received were as follows: The patient received Shingrix on Tuesday this week, the day before reporting date. The patient's blood glucose was elevated out of his normal range. The contact stepped away from chat, no further information provided.
Miscarriage of early term pregnancy. I discovered I was pregnant the week after receiving the vaccination. I began to cramp and bleed within three weeks resulting in a miscarriage on Sept 12, 2021.
Belt like rash, unilateral, blisters, itchy on red base ----> shingles 10/26/07 Varivax 12/23/98, 10/12/07
I had had minor intermittent teeth pain off and on for several weeks. With in a day of getting the vaccine the pain began increasing to the whole left side of my face and neck and increasing in intensity. I was unable to sleep 12/24 and 12/25 and ended up going to urgent care on 12/26. Despite not having sinus fullness/drainage they diagnosed it a sinus infection and gave me antibiotics. At the end of the 5 day course my symptoms had improved some but were not gone and I was still requiring frequent Tylenol for pain so the course of antibiotics were extended. I do not know if this was caused by the vaccine, but it coincided with the vaccine.
Approximately 12 hours after injection complained of localized pain/swelling in both injection sites,  with more pain, and itching on left side (Bexsero).  Reported hives, mild chest tightness and swelling of lips and left ear.
Pt broke out In rash immediately after vaccination administered, he was given 25mg Benadryl on site. Pt was transferred out to Hospital to receive care.
This is a spontaneous report from a contactable pharmacist. A 70 year-old male patient received PREVNAR 13 (lot R45377, expiry date 01Dec2017, NDC 00005197102) intramuscular in the right deltoid on 12Dec2016 at 0.5 ml single for immunization. Medical history included ongoing arthritis, ongoing diabetes, ongoing gout. Concomitant medications included ongoing glipizide 10 mg tablet since Jun2016 at 10 mg twice a day oral for diabetes, ongoing colchicine 0.5 mg tablet since 27Mar2017 at 0.5 mg twice a day oral for gout, ongoing gabapentin 600 mg tablet since Apr2014 at 600 mg thrice a day oral and indomethacin . The patient experienced sore and numb arm on an unspecified date. No laboratory works were done. The patient was not recovered from the reported events.
THE VACCINATION WAS DONE 10-09-2019 AS OF 10-19-2019 I STILL HAVE A LARGE BRUISE AS IF MY SKIN WAS BURNED
I started having nasal congestion, it felt like a head cold. I went to get checked because I need to travel for work. They came out to the car swabbed my nose and called me back to let me know that I was positive for COVID-19. I was advised to quarantine for five days and if I feel better on day six, I can go out with a mask for five days. I have been running a fever since yesterday but other than that this feels more like a head cold.
Extreme sensitivity of tongue. Mildly acidic foods cause pain. Spicy foods cause pain. Carbonated beverages cause pain. Mild numbness in lips. Has persisted for 5 days since symptoms started.  Started two days after immunization. No history of mouth sensitivity.
mom states pt slept excessively for 3 days;mom owke pt for feeding q 3-4hr;pt nursed for 5-10min & back to sleep;did not call MD to report any concerns;gave DT for second visit 28APR97;
Fever of 101, chills and profound weakness. Patient was unable to ambulate. Patient was admitted due to these symptoms
sickest; Initial information regarding an unsolicited valid non-serious case was received from a consumer (patient) via social media on 17-Dec-2020.  This case involves a patient of an unknown demographics who was sickest (illness), after receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, past vaccinations, family history and concomitant medications were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient was sickest (illness), (non-serious event) (unknown latency) following the administration of INFLUENZA VACCINE.   No laboratory data was reported.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome was unknown for the events.  There will be no information available on the batch number for this case.
Expired Infanrix administered; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 18-month-old female patient who received DTPa (Infanrix) (batch number XG942, expiry date 22nd August 2022) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 9th September 2022, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 9th September 2022, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 09-SEP-2022 Reporter's Comment: The reporter was a nurse. The reporter reported that the patient received an expired dose of Infanrix vaccine. The reporter consented to follow up. Additional supportive information: The patient received a Infanrix which was already expired, which led to expired vaccine used.
Initial unsolicited report received from a consumer (patient herself) on 02-May-2018. This case involves a female patient (age was not reported), who was vaccinated with a dose of DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (TDAP) (Batch number, expiry date, dose, dose in series, route and site of administration were not reported) on 28-Mar-2018 at physician's office. Patient's medical history and concomitant medications were not reported. On an unknown date, three days following the vaccination the patient had a large, hard lump at injection site of right arm, extending to the shoulder and to neck area, painful and could not move her right arm without difficulty. Laboratory investigations and corrective treatment was not reported. The patient was not yet recovered/resolved from all the events. List of documents held by sender: none.
Red ring on arm after 1st dose; Sick feeling after 1st dose; Nauseated; Headache; Fever; Chills after 1st dose; Sore arm after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red ring on arm after 1st dose), MALAISE (Sick feeling after 1st dose), NAUSEA (Nauseated), HEADACHE (Headache) and PYREXIA (Fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (COVID-19) on 15-Jan-2021.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Red ring on arm after 1st dose), MALAISE (Sick feeling after 1st dose), NAUSEA (Nauseated), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills after 1st dose) and VACCINATION SITE PAIN (Sore arm after 1st dose). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Red ring on arm after 1st dose) and VACCINATION SITE PAIN (Sore arm after 1st dose) outcome was unknown and MALAISE (Sick feeling after 1st dose), NAUSEA (Nauseated), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills after 1st dose) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Body temperature: 99.8 (High) 99.8 to 101.7. On 15-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. The symptoms didn't last long and the patient had  started feeling better after about one day.
Unclear relationship to autoimmune myositis, patient was on statin for some time previously (>2 years) and onset was the same date as influenza vaccine and just over 2 weeks from moderna vaccine
an expired dose of fluzone high dose quadrivalent was inadvertently administered with no reported adverse event; Initial information received on 08-Sep-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 74 years old female patient to whom an expired dose of fluzone high dose quadrivalent was inadvertently administered with no reported adverse event while receiving vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 08-Sep-2022, the patient received 0.7 mL dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot UJ769AC, expiry date: 30-Jun-2022) via intramuscular route in the left deltoid for prophylactic immunization.  On 08-Sep-2022, (latency: same day) the patient had an expired dose of fluzone high dose quadrivalent was inadvertently administered with no reported adverse event (expired product administered) following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE.  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
very high fever 105 degF after vaccination. Fevers started late in the same night as vaccines were given per mom.
Patient has congestion, runny nose, loss of taste and smell. Husband has congestion and runny nose.
Discharge Provider:  DO Primary Care Provider:  MD Admission Date: 9/25/2022 Discharge Date: 9/29/2022   PRESENTING PROBLEM: Weakness [R53.1]   HOSPITAL COURSE:   Patient is 87-year-old male with history of combine systolic and diastolic heart failure with EF of 20%, CVA with left-sided residual, atrial flutter on warfarin, and seizure disorder, who presented to hospital with increasing weakness difficulty walking, low appetite cough and was found to be COVID positive.  He also was found to be in acute on chronic combine systolic and diastolic heart failure exacerbation.  He was not a candidate for antiviral medication.  He was treated with doxycycline, prednisone and antitussives medication. He was also treated with IV lasix for acute on chronic systolic and diastolic heart failure.  He was recommended for subacute rehab, but patient declined as he have extensive home health services arranged and also have a caregiver. His wife have dementia. Note that he was subtherapeutic on INR, warfarin increase to 4 mg daily.  He will need to follow up with warfarin Clinic for further management.  He also need to follow up with primary care doctor and cardiologist to assess indication for beta-blocker and spironolactone.  These medications were not started during this hospitalization due to somewhat low blood pressure and bradycardia.  COVID Assessment & Plan Oxygen at home baseline Not a candidate for anti-virals Treated with prednisone 40 mg daily; discharged with 2 more days His CXR did have basilar opacity (likely viral PNA, but could be superinfected with bacteria), sputum is dark brown  Treated with and discharged on robitussin as needed and doxycycline for 6 additional days
This spontaneous report was received from a Licensed Practical Nurse regarding a 19 year and 8 months old patient. There was no information about concomitant medication and historical medication. On 28-JAN-2014, the patient was vaccinated with RECOMBIVAX HB lot # L000717 dose 1, on 04-MAR-2014 dose 2 and the patient who was now 19 years and 8 months old received dose 3 on 02-MAR-2016, lot # L000717 and this was outside the recommended per the RECOMBIVAX HB prescribing information. No adverse event was reported. The outcome of the event was unknown. Additional information has been requested.
swelling, inflamed, itching, sore. Began a couple hours after shot on 10/7 and persisted and ongoing.
Shortly after leaving vaccine site, my tongue began to tingle, and I became having nausea.  I was extremely.  Tired.  On 2/5/21 I began having muscle and joint pain.  Tylenol helped with the symptoms.  Nausea has continued off and on up to today.  Today, 2/15/21 I noticed the area around the injection site was red and quite hot.  I began to itch.    I have a call into my doctor but still no response.  The itching has lessened but the arm area is still red and hot.
Numbness in face on the same side of the body as the injection site. It persisted for multiple days and gradually decreased over that time. The sensation was similar to having a numbing shot for dental work and that medicine wearing off over a couple of days rather than a few hours. My doctor instructed me that it was likely inflammation affecting the nerves as a result of the injection and that use of Advil or a similar product would help.
Metallic taste in mouth and dry mouth.; Metallic taste in mouth and dry mouth.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 77 year-old female patient (not pregnant) received bnt162b2 (BNT162B2, solution for injection), administered in arm left, administration date 22Jan2021 12:45 (Lot number: EL3249) at the age of 77 years as dose 1, single and administration date 15Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "No" (unspecified if ongoing). Concomitant medication(s) included: ALENDRONATE; CALCIUM; AREDS. The following information was reported: DYSGEUSIA (non-serious), DRY MOUTH (non-serious), outcome "not recovered" and all described as "Metallic taste in mouth and dry mouth.". Therapeutic measures were not taken as a result of dysgeusia, dry mouth.  Additional information: Clinical course included 'Metallic taste in mouth and dry mouth. Not sure if this started with 1st or 2nd (15Feb2021) inoculation. Have been wondering what was causing this taste and dryness but didn't connect this initially with vaccination until I looked up the subject and found other people experiencing the same thing after the vaccinations'  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a healthcare worker concerning a patient of unknown age and gender. It was reported that on an unknown date, the patient may have received a dose of RECOMBIVAX HB (manufacturer unknown) (lot number, expiry date, dose and route unspecified). It was unclear if the patient received the vaccine. No concomitant therapy was reported. On an unknown date, the patient failed to seroconvert. The outcome of the event was unknown. The relatedness for the event was unknown for RECOMBIVAX HB (manufacturer unknown). Additional information has been requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 19Sep2022 as dose 5 (booster), single (Lot number: GH9694) at the age of 66 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 05Mar2021 as dose 1, single (Lot number: EN6204), in left arm, on 26Mar2021 as dose 2, single (Lot number: ER8733), in left arm, on 02Oct2021 as dose 3 (booster), single (Lot number: 301558A), in left arm and on 18Apr2022 as dose 4 (booster), single (Lot number: FK9895), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hyperlipidemia" (unspecified if ongoing); "osteoporosis" (unspecified if ongoing); "microscopic colitis" (unspecified if ongoing), notes: microscopic colitis. Concomitant medication(s) included: ALENDRONATE, start date: 09Dec2021; ROSUVASTATIN, stop date: 09Dec2021; GLUCOSAMINE & CHONDORITIN; COENZYME Q10+; CALCIUM CITRATE WITH VITAMIN D; LUTEIN-ZEAXANTHIN; and MULTIVITAMINS. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Mar2023, all described as "Treatment of COVID-19". Therapeutic measures (Paxlovid) were taken as a result of vaccination failure, covid-19. Outcome of the events was unknown.
In 1994, during annual training, our company was given shots. That night I passed out and was taken to the medical aid station.
severe hives on back/var/folders/1z/zbry6j8n0r1737cgrdfybb9r0000gn/T/com.apple.mail/com.apple.mail.drag-T0x6000023acbc0.tmp.BsUCMb/Attachment-1.jpeg
PATIENT WITH CHRONIC HYPOXIC RESP FAILURE WITH HOME O2 AT 4L. HAD RECENT HOSPITALIZATION FOR COVID PNE. PRESENTED TO A MEDICAL CENTER DUE TO WORSENING SHORTNESS OF BREATH. O2 INCREASED TO 7L INCREASE WEAKNESS NOTED. EMS CALLED AND BROUGHT TO ER. PATIENT TRANSFERRED TO ANOTHER MEDICAL CENTER FOR HIGHER LEVEL OF CARE. PT DIAGNOSED WITH BILATERAL  PNEUMONIA.
Not symptomatic until Monday AM - developed hives to both arms, neck, and face - red, raised wells - Pt self treated with benedryl and hydrocortisone cream
Constant headache since the nite after the vaccine.  Some headaches are really bad,  almost migrane level occurring on right side of temple.  After a month,  headaches are not as bad, still persistent.   Dizziness to the point that i have gotten nausea 5 out of 5 times being a passenger in a car,  2 of those times vomiting.  Driving a car is fine with no dizziness or car sickness.   2 intense bouts of vertigo, starting 1 week after the vaccine  Could hardly walk,  bumping into things, like  i got off a spinning carnival ride drunk.   I took zanax and went to bed,  and woke up fine.    Overheating,  hot flashes,  and fatigue also come and go.